賓達汀凍晶注射劑

Country: Թայվան

language: չինարեն

source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

active_ingredient:

BENDAMUSTINE HYDROCHLORIDE

MAH:

健喬信元醫藥生技股份有限公司 新竹縣湖口鄉工業一路6號 (43199950)

ATC_code:

L01AA09

pharmaceutical_form:

凍晶注射劑

composition:

BENDAMUSTINE HYDROCHLORIDE (1004002510) MG; TERTIARY-BUTYL ALCOHOL (9600208100) MG

units_in_package:

盒裝

class:

製　劑

prescription_type:

限由醫師使用

manufactured_by:

INTAS PHARMACEUTICALS LIMITED PLOT NO. 5 TO 14, PHARMEZ, NEAR VILLAGE MATODA, TAL: SANAND, CITY: MATODA, DIST: AHMEDABAD, GUJARAT STATE, INDIA IN

therapeutic_area:

bendamustine

therapeutic_indication:

1.Binet分類stage B及C之慢性淋巴球白血病(chronic lymphocytic leukemia,CLL)。2.曾接受至少一種化療之和緩性非何杰金氏淋巴瘤，六個月內曾以rituximab治療失敗之單一治療。3.Bendamustine合併Rituximab適用於先前未曾接受治療的CD20陽性、第 III / IV 期和緩性非何杰金氏淋巴癌(non-hodgkin lymphoma, NHL)。Bendamustine合併Rituximab適用於先前未曾接受治療且不適合自體幹細胞移植的第 III / IV 期被套細胞淋巴癌(mantle cell lymphoma, MCL)。

leaflet_short:

有效日期: 2028/08/09; 英文品名: Bendine Powder for Solution for Infusion

authorization_date:

2023-08-09